IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion	Adrenal incidentaloma, Body Weight, Body Weight Changes, Cushing syndrome, Insulin Resistance, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, adrenal gland disorder, adrenal gland hyperfunction, ectopic ACTH secretion syndrome, endocrine system disorder, glucose metabolism disease, hyperinsulinism, metabolic disease, neoplasm, paraneoplastic syndrome	Recruiting	Not applicable	2026-03-27		NCT07361874

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)	617
University of Texas Southwestern Medical Center	295

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Texas Southwestern Medical Center	Dallas	United States	249